Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1010 | 967 | 1149 | 937 | 1180 | 2108 |
Fund Return | 0.96% | -3.29% | 14.92% | -2.16% | 3.37% | 7.74% |
Place in category | 339 | 153 | 333 | 239 | 306 | 84 |
% in Category | 76 | 34 | 72 | 68 | 91 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund A DIST EUR | 9.84B | 16.95 | 11.11 | 20.46 | ||
Global Technology Fund E Acc EUR | 1.17B | 16.22 | 10.28 | 19.57 | ||
Global Technology Fund Y Acc EUR | 1.9B | 17.82 | 12.06 | 21.47 | ||
Global Technology Fund Y DIST EUR | 581.18M | 17.79 | 12.07 | 21.46 | ||
Fidelity Global Technol A-Acc-EUR | 2.88B | 16.96 | 11.11 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth A EUR | 3.17B | 0.68 | -4.35 | 7.00 | ||
Allianz Europe Equity Growth AT EUR | 3.17B | 0.68 | -4.35 | 6.99 | ||
Allianz Europe Equity Growth P EUR | 3.17B | 1.40 | -3.53 | 7.91 | ||
Allianz Europe Equity Growth I EUR | 3.17B | 1.43 | -3.50 | 7.95 | ||
Allianz Europe Equity Growth PT EUR | 3.17B | 1.40 | -3.54 | 7.91 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Experian | GB00B19NLV48 | 7.26 | 3,710.0 | +2.18% | |
Relx | GB00B2B0DG97 | 6.46 | 3,613.00 | +1.92% | |
SAP | DE0007164600 | 5.40 | 224.700 | +1.86% | |
Air Liquide | FR0000120073 | 3.83 | 159.26 | +0.76% | |
Coloplast | DK0060448595 | 3.60 | 873.2 | -0.89% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review